Zimmer Biomet Holdings (ZBH) free cash flow

Free cash flow · fiscal 2025
$1.42B

Zimmer Biomet Holdings (ZBH) generated free cash flow of $1.42B in fiscal 2025 (the year ended December 31, 2025). That is 24.3% higher than the $1.14B of fiscal 2024. Figures as of 18 Nov 2026, 12:14 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$1.42B
Change on fiscal 2024
+24.3%
Growth, 5 years
+5.4% a year
Growth, 10 years
+7.6% a year
Highest on record
$1.58Bfiscal 2018
Lowest on record
$682.10Mfiscal 2015
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Zimmer Biomet Holdings free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow grew at a compound 5.4% a year; over ten years the rate was 7.6% a year. Across the 19 fiscal years on record (2007–2025), the highest was $1.58B in fiscal 2018 and the lowest $682.10M in fiscal 2015.

History · 19 fiscal years

Free cash flow by fiscal year

Zimmer Biomet Holdings free cash flow, year by year

Zimmer Biomet Holdings (ZBH) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$1.42B 24.3% up
2024$1.14B 3.7% down
2023$1.19B 11.2% up
2022$1.07B 21.3% down
2021$1.36B 24.1% up
2020$1.09B 20.8% down
2019$1.38B 13.0% down
2018$1.58B 11.1% up
2017$1.43B 1.5% down
2016$1.45B 112.2% up
2015$682.10M 25.5% down
2014$915.60M 6.1% up
2013$863.10M 16.8% down
2012$1.04B 2.4% down
2011$1.06B 4.6% down
2010$1.11B 10.1% up
2009$1.01B 28.5% up
2008$788.10M 11.6% down
2007$891.70M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Zimmer Biomet Holdings and comparable companies
CompanyFree cash flowFiscal year
Tenet Healthcare THC$2.53B2025
BioNTech BNTX-€293.00M2025
Guardant Health GH-$233.07M2025
Alnylam Pharmaceuticals ALNY$465.38M2025
Zimmer Biomet Holdings ZBH$1.42B2025
Medpace Holdings MEDP$681.87M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ZBH

Zimmer Biomet Holdings, figure by figure

Zimmer Biomet Holdings (ZBH) overview: price, valuation and scorecardAll health care companies by market value

Zimmer Biomet Holdings free cash flow: questions and answers

What is Zimmer Biomet Holdings's free cash flow?

Zimmer Biomet Holdings (ZBH) generated free cash flow of $1.42B in fiscal 2025 (the year ended December 31, 2025). That is 24.3% higher than the $1.14B of fiscal 2024.

What is the growth rate of Zimmer Biomet Holdings's free cash flow?

Over the five fiscal years to 2025 free cash flow grew at a compound 5.4% a year; over ten years the rate was 7.6% a year.

What are the highest and lowest free cash flow figures on record for Zimmer Biomet Holdings?

Across the 19 fiscal years on record (2007–2025), the highest was $1.58B in fiscal 2018 and the lowest $682.10M in fiscal 2015.

How is Zimmer Biomet Holdings's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Zimmer Biomet Holdings it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Zimmer Biomet Holdings (ZBH) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/ZBH/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.